Suministro de Fármacos para Consultorio Miraflores
Se requiere suscribir contrato de suministro para fármacos para cubrir quiebres de stock en el establecimiento, por incumplimiento de programación mensual de Programas Ministeriales del establecimiento, indicados en el siguiente punto, por 18 meses, pudiendo ser renovado, por una sola vez, hasta por 6 meses más, por razones fundadas y sólo para los efectos de preparar una nueva licitación.
13 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1382-431-SE26 | 14-05-2026 | Guillermo Harding y Compania Limitada | $299.880 |
| 1382-341-SE26 | 13-04-2026 | Guillermo Harding y Compania Limitada | $449.820 |
| 1382-223-SE26 | 10-03-2026 | Itf Farma Chile S.A. | $190.400 |
| 1382-216-SE26 | 09-03-2026 | Guillermo Harding y Compania Limitada | $299.880 |
| 1382-167-SE26 | 17-02-2026 | Winpharm SpA | $183.260 |
| 1382-168-SE26 | 17-02-2026 | Guillermo Harding y Compania Limitada | $299.880 |
| 1382-165-SE26 | 17-02-2026 | Salcobrand S.A. | $306.128 |
| 1382-166-SE26 | 17-02-2026 | Itf Farma Chile S.A. | $142.800 |
| 1382-33-SE26 | 13-01-2026 | Guillermo Harding y Compania Limitada | $1.132.464 |
| 1382-36-SE26 | 13-01-2026 | Salcobrand S.A. | $437.325 |
| 1382-1045-SE25 | 10-12-2025 | Guillermo Harding y Compania Limitada | $1.656.575 |
| 1382-1049-SE25 | 10-12-2025 | Salcobrand S.A. | $204.085 |
| 1382-1042-SE25 | 10-12-2025 | Itf Farma Chile S.A. | $142.800 |
| 1382-952-SE25 | 11-11-2025 | Guillermo Harding y Compania Limitada | $1.132.464 |
| 1382-835-SE25 | 10-10-2025 | Guillermo Harding y Compania Limitada | $24.562 |
| 1382-833-SE25 | 10-10-2025 | Itf Farma Chile S.A. | $285.600 |
| 1382-837-SE25 | 10-10-2025 | Opko Chile S.A. | $499.800 |
| 1382-754-SE25 | 09-09-2025 | Itf Farma Chile S.A. | $142.800 |
| 1382-756-SE25 | 09-09-2025 | Guillermo Harding y Compania Limitada | $799.430 |
| 1382-650-SE25 | 07-08-2025 | Ethon Pharmaceuticals Ltda. | $37.842 |
| 1382-653-SE25 | 07-08-2025 | Guillermo Harding y Compania Limitada | $949.370 |
| 1382-605-SE25 | 14-07-2025 | Guillermo Harding y Compania Limitada | $1.448.920 |
| 1382-601-SE25 | 14-07-2025 | Astrazeneca S.A. | $129.389 |
| 1382-602-SE25 | 14-07-2025 | Ethon Pharmaceuticals Ltda. | $37.842 |
| 1382-496-SE25 | 10-06-2025 | Guillermo Harding y Compania Limitada | $1.132.464 |
| 1382-493-SE25 | 10-06-2025 | Astrazeneca S.A. | $388.166 |
| 1382-395-SE25 | 09-05-2025 | Winpharm SpA | $78.540 |
| 1382-386-SE25 | 09-05-2025 | Astrazeneca S.A. | $388.166 |
| 1382-394-SE25 | 09-05-2025 | Guillermo Harding y Compania Limitada | $299.880 |
| 1382-319-SE25 | 04-04-2025 | Winpharm SpA | $157.080 |
| 1382-318-SE25 | 04-04-2025 | Guillermo Harding y Compania Limitada | $1.132.464 |
| 1382-315-SE25 | 04-04-2025 | Astrazeneca S.A. | $388.166 |
| 1382-250-SE25 | 19-03-2025 | Winpharm SpA | $157.080 |
| 1382-247-SE25 | 19-03-2025 | Itf Farma Chile S.A. | $428.400 |
| 1382-245-SE25 | 19-03-2025 | Ethon Pharmaceuticals Ltda. | $56.763 |
| 1382-249-SE25 | 19-03-2025 | Guillermo Harding y Compania Limitada | $1.473.482 |
| 1382-159-SE25 | 12-02-2025 | Guillermo Harding y Compania Limitada | $1.448.920 |
| 1382-153-SE25 | 12-02-2025 | Astrazeneca S.A. | $517.555 |
| 1382-155-SE25 | 12-02-2025 | Ethon Pharmaceuticals Ltda. | $56.763 |
| 1382-157-SE25 | 12-02-2025 | Itf Farma Chile S.A. | $285.600 |
| 1382-42-SE25 | 09-01-2025 | Guillermo Harding y Compania Limitada | $823.992 |
| 1382-43-SE25 | 09-01-2025 | Winpharm SpA | $157.080 |
| 1382-44-SE25 | 09-01-2025 | Ethon Pharmaceuticals Ltda. | $56.763 |
| 1382-41-SE25 | 09-01-2025 | Astrazeneca S.A. | $517.555 |
| 1382-990-SE24 | 23-12-2024 | Guillermo Harding y Compania Limitada | $799.430 |
| 1382-991-SE24 | 23-12-2024 | Winpharm SpA | $157.080 |
| 1382-989-SE24 | 23-12-2024 | Astrazeneca S.A. | $388.166 |
| 1382-892-SE24 | 12-11-2024 | Ethon Pharmaceuticals Ltda. | $96.509 |
| 1382-893-SE24 | 12-11-2024 | Guillermo Harding y Compania Limitada | $823.992 |
| 1382-894-SE24 | 12-11-2024 | Winpharm SpA | $157.080 |
| 1382-891-SE24 | 12-11-2024 | Astrazeneca S.A. | $388.166 |
| 1382-814-SE24 | 15-10-2024 | Guillermo Harding y Compania Limitada | $799.430 |
| 1382-816-SE24 | 15-10-2024 | Winpharm SpA | $157.080 |
| 1382-817-SE24 | 15-10-2024 | Ethon Pharmaceuticals Ltda. | $91.606 |
| 1382-812-SE24 | 15-10-2024 | Astrazeneca S.A. | $388.166 |
| 1382-743-SE24 | 13-09-2024 | Ethon Pharmaceuticals Ltda. | $56.763 |
| 1382-742-SE24 | 13-09-2024 | Itf Farma Chile S.A. | $1.190.000 |
| 1382-740-SE24 | 12-09-2024 | Guillermo Harding y Compania Limitada | $624.322 |
| 1382-739-SE24 | 12-09-2024 | Astrazeneca S.A. | $388.166 |
| 1382-646-SE24 | 22-08-2024 | Ethon Pharmaceuticals Ltda. | $67.473 |
| 1382-645-SE24 | 22-08-2024 | Guillermo Harding y Compania Limitada | $582.838 |
| 1382-547-SE24 | 09-07-2024 | Ethon Pharmaceuticals Ltda. | $67.473 |
| 1382-549-SE24 | 09-07-2024 | Guillermo Harding y Compania Limitada | $383.168 |
| 1382-550-SE24 | 09-07-2024 | Novofarma Service S.A. | $959.140 |
| 1382-544-SE24 | 09-07-2024 | Astrazeneca S.A. | $388.166 |
| 1382-483-SE24 | 10-06-2024 | Novofarma Service S.A. | $368.900 |
| 1382-484-SE24 | 10-06-2024 | Salcobrand S.A. | $204.085 |
| 1382-485-SE24 | 10-06-2024 | Winpharm SpA | $157.080 |
| 1382-486-SE24 | 10-06-2024 | Guillermo Harding y Compania Limitada | $1.132.464 |
| 1382-482-SE24 | 10-06-2024 | Ethon Pharmaceuticals Ltda. | $56.763 |
| 1382-360-SE24 | 08-05-2024 | Itf Farma Chile S.A. | $476.000 |
| 1382-362-SE24 | 08-05-2024 | Novofarma Service S.A. | $737.800 |
| 1382-363-SE24 | 08-05-2024 | Salcobrand S.A. | $204.085 |
| 1382-364-SE24 | 08-05-2024 | Winpharm SpA | $235.620 |
| 1382-359-SE24 | 07-05-2024 | Astrazeneca S.A. | $388.166 |
| 1382-358-SE24 | 07-05-2024 | Ethon Pharmaceuticals Ltda. | $56.763 |
Fuente original:ficha mercadopublico.cl
